| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| YOUNG MORRIS S | CEO | 4281 TECHNOLOGY DR., FREMONT | /s/ Jeff Sensiba, Attorney-in-Fact | 08 Dec 2025 | 0001078582 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXTI | Common Stock | Options Exercise | $100,001 | +32,680 | +1.3% | $3.06 | 2,494,040 | 04 Dec 2025 | Direct | F1 |
| transaction | AXTI | Common Stock | Options Exercise | $100,000 | +17,331 | +0.69% | $5.77 | 2,511,371 | 04 Dec 2025 | Direct | F2 |
| transaction | AXTI | Common Stock | Options Exercise | $99,996 | +19,193 | +0.76% | $5.21 | 2,530,564 | 04 Dec 2025 | Direct | F3 |
| transaction | AXTI | Common Stock | Sale | $421,750 | -35,000 | -1.4% | $12.05 | 2,495,564 | 04 Dec 2025 | By Young Family Trust DTD | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXTI | Stock Option (Right to Buy) | Options Exercise | $0 | -32,680 | -5.3% | $0.000000 | 589,273 | 04 Dec 2025 | Common Stock | 32,680 | $3.06 | Direct | F5 |
| transaction | AXTI | Stock Option (Right to Buy) | Options Exercise | $0 | -17,331 | -2.9% | $0.000000 | 571,942 | 04 Dec 2025 | Common Stock | 17,331 | $5.77 | Direct | F6 |
| transaction | AXTI | Stock Option (Right to Buy) | Options Exercise | $0 | -19,193 | -3.4% | $0.000000 | 552,749 | 04 Dec 2025 | Common Stock | 19,193 | $5.21 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Exercise of restricted stock awards which were originally granted on 11/06/2019 and became first exercisable on 11/06/2020. |
| F2 | Exercise of restricted stock awards which were originally granted on 11/05/2018 and became first exercisable on 11/05/2019. |
| F3 | Exercise of restricted stock awards which were originally granted on 10/28/2016 and became first exercisable on 10/28/2017. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.92 to $12.13,inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate transaction. |
| F5 | Exercise of restricted stock awards which were originally granted on 11/06/2019 and became first exercisable on 11/06/2020. |
| F6 | Exercise of restricted stock awards which were originally granted on 11/05/2018 and became first exercisable on 11/05/2019. |
| F7 | Exercise of restricted stock awards which were originally granted on 10/28/2016 and became first exercisable on 10/28/2017. |